An adjustment to the 1997 estimate for new prostate cancer cases

Ca-A Cancer Journal for Clinicians

Volumn 47, Issue 4, 1997, Pages 239-242

  Wingo, Phyllis A ^a   Landis, Sarah ^a   Ries, Lynn A G ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INCIDENCE; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

EID: 0030870878     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.47.4.239     Document Type: Article

References (8)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics. 1997. CA Cancer J Clin 1997;47:5-27.
2. Ries LAG, Kosary CL, Hankey BF, et al (eds) SEER Cancer Statistics Review. 1973-1993: Tables and Graphs (NIH Pub. 96-2789). Bethesda. MD. National Cancer Institute. 1996.
3. Gilliland FD, Welsh DJ, Hoffman RM, et al: Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico. 1989-1993. Cancer Epidemiol Biomasrkers Prev 1995;4:797-800.
4. Stephenson RA, Smart CR, Mineau GP, et al: The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence - data from the Utah cancer reg istry. Cancer 1996;77:1342-1348.
5. Merrill RM, Brawley OW: Prostate cancer incidence and mortality rates among black and white men. Epidemiology 1997;8:126-131.
6. Potosky AL, Miller BA, Albertsen PC, et al: The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-552.
7. Gann PW: Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 1997;8:117-120.
8. Howe HL, Lehnherr M (eds): Cancer in North America. 1989-1993. Vol. 1: Incidence. Sacramento CA: North American Association of Central Cancer Registries. April 1997.